Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and... see more

TSXV:THRM - Post Discussion

Therma Bright Inc > did AcuVid study/trial include patients with CTcounts over30
View:
Post by jpm59 on May 31, 2022 9:56am

did AcuVid study/trial include patients with CTcounts over30

I read SONA March 20th NR update & it discussed the ct count for under 30 & over 30. They were not successful in results for patients with ct ccount over 30(lighter viral load than under 30). Seems to me this was discussed in the past regarding Acuvid,, I looked at past NR's & can't see it but am sure the study was successful for under 30 which I thought was the required threshold. Things change so not sure if anyone knows about what threshold is  required. Also it seems SONA study may of had less participants than THRM. I am not a scientist but just wondering about is there a need/requirement for the study/test to pick the virus with a count over 30?
Comment by martindale on May 31, 2022 11:19am
As per June 17 2021. “  The ongoing clinical study for our AcuVid™ COVID-19 Rapid Antigen Saliva Test has performed extremely well," expressed Therma's CEO Rob Fia. "As of June 16th, 63 subjects were enrolled and provided a nasal swab for a RT-PCR test and a saliva sample for the AcuVid™ test. Of the 63, RT-PCR results were received for 56 subjects, with 28 positive and 28 ...more  
Comment by nrv090909 on May 31, 2022 1:59pm
Canadian government might be dropping vaccine mandate in airports to fly likely in 2 months time. Come on Therma, let's get going here with Acuvid. 
Comment by martindale on May 31, 2022 3:11pm
......Calling BS on that one.. the mighty Turd likes being a DiCKtator..... https://tnc.news/2022/05/30/liberals-vote-against-motion-to-end-covid-restrictions-for-travellers/
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities